Dassault Systèmes SE is a leading global provider of sophisticated software solutions and related services. The company's diverse product portfolio addresses a wide range of industry requirements, including SOLIDWORKS for integrated 3D design, electrical and PCB design, product data management, simulation, and manufacturing, as well as CATIA for advanced 3D computer-aided design and engineering. Other specialized offerings include GEOVIA for earth modeling and simulation, BIOVIA for supporting scientific endeavors in biology, chemistry, and materials, and SIMULIA for delivering highly realistic simulation applications. For operational excellence and collaboration, Dassault Systèmes provides DELMIA for optimizing global industrial processes, 3DVIA for 3D space planning, and ENOVIA for planning and tracking customer success throughout a product's lifecycle. Their Centric PLM solution manages product lifecycles, while 3DEXCITE offers real-time 3D visualization. NETVIBES is designed to aggregate, align, and enhance big data insights. A cornerstone of their ecosystem is the 3DEXPERIENCE platform, which offers a unified environment for a holistic, real-time view of business operations, connecting people, ideas, and data. Furthermore, MEDIDATA provides critical software for clinical research studies, benefiting pharmaceutical, biotech, medical device, diagnostic companies, and academic researchers. Beyond its extensive software suite, the company also offers a comprehensive range of consulting, deployment, outcome-based, and training services. Dassault Systèmes serves a broad array of sectors, including transportation and mobility, aerospace and defense, high-tech, life sciences and healthcare, energy and materials, and consumer goods, distributing its solutions through a network of distributors and resellers. The company was founded in 1981 and maintains its headquarters in Vélizy-Villacoublay, France.
globenewswire.comDassault Systèmes: declaration of the number of outstanding shares and voting rights as of May 31, 2026globenewswire.comJun 8
fool.comRecursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?fool.comJun 2
seekingalpha.comDassault Systemes: Downgrade To Hold As The Timing To Growth Acceleration Is Uncertainseekingalpha.comMay 12
globenewswire.comDassault Systèmes: declaration of the number of outstanding shares and voting rights as of April 30, 2026globenewswire.comMay 11
globenewswire.comCombined General Shareholders' Meeting of May 20, 2026: availability of preliminary documentsglobenewswire.comApr 29